Sort
21,453 grants matching “tuberculosis”
Uganda HIV/TB COHRE Training Program
$140,246Christopher C. Whalen · Case Western Reserve University · U2R · FY2008 · TW
Developing a clinical cohort of histopathologically characterized lymphoma
$140,175Satish Gopal · Univ Of North Carolina Chapel Hill · K01 · FY2013 · TW
Developing a clinical cohort of histopathologically characterized lymphoma
$140,175Satish Gopal · Univ Of North Carolina Chapel Hill · K01 · FY2015 · TW
Developing a clinical cohort of histopathologically characterized lymphoma
$140,175Satish Gopal · Univ Of North Carolina Chapel Hill · K01 · FY2012 · TW
Developing a clinical cohort of histopathologically characterized lymphoma
$140,175Satish Gopal · Univ Of North Carolina Chapel Hill · K01 · FY2014 · TW
Developing a clinical cohort of histopathologically characterized lymphoma
$140,175Satish Gopal · Univ Of North Carolina Chapel Hill · K01 · FY2016 · TW
Immunology and Infectious Diseases
$140,171Laurie H Glimcher · Harvard School Of Public Health · T32 · FY2008 · AI
Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort
$140,152Jesse Gitaka · Mount Kenya University · R01 · FY2025 · AI
Immunology and Infectious Diseases
$140,133Laurie H Glimcher · Harvard School Of Public Health · T32 · FY2009 · AI
UC Davis-China Infectious Disease Research Training
$140,098Kathryn Deriemer · University Of California At Davis · D43 · FY2011 · TW
UC Davis-China Infectious Disease Research Training
$140,098Kathryn Deriemer · University Of California At Davis · D43 · FY2009 · TW
UC Davis-China Infectious Disease Research Training
$140,098Kathryn Deriemer · University Of California At Davis · D43 · FY2012 · TW
TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTING
$140,000Colorado State University-Fort Collins · N01 · FY2000 · AI
EVALUATION OF ALASKAN PLANTS FOR TUBERCULOSIS TREATMENT
$140,000Alaska Green Gold Company · R43 · FY2003 · AT
Flow Cytometry Core
$139,999Steven A Porcelli · Albert Einstein College Of Medicine · P01 · FY2014 · AI
A Better & Stable Cold High-Level Disinfectant Formulation for Medical Equipments
$139,980Rajiv Kumar Satsangi · Rann Research Corporation · R43 · FY2009 · AI
Immunology and Infectious Diseases
$139,974Laurie H Glimcher · Harvard School Of Public Health · T32 · FY2006 · AI
Developing vault nanoparticles as a delivery platform for Burkholderia pseudomallei and Burkholderia mallei antigens
$139,888Christopher Todd French · University Of California Los Angeles · R21 · FY2019 · AI
Immunology and Infectious Diseases
$139,841Harvard University (Sch Of Public Hlth) · T32 · FY2005 · AI
A biophysical assay for RNA based resistance
$139,801Sandra Paige Story · Nubad, Llc · R43 · FY2021 · AI
CRDF GLOBAL WILL PROVIDE FIDUCIARY SUPPORT TO CDC TO MANAGE TB-RELATED ACTIVITIES
$139,781Shawn Trenton Wheeler · U S Civilian Research/ Development Fdn · U01 · FY2016 · PS
Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort
$139,778Jesse Gitaka · Mount Kenya University · R01 · FY2024 · AI
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
$139,772David Crich · Wayne State University · R01 · FY2019 · AI
Cognitive and Neurologic Sequelae in Cerebral Malaria
$139,750Case Western Reserve University · R21 · FY2003 · TW
Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis
$139,720Elizabeth Maria Streicher · Stellenbosch University · R01 · FY2021 · AI